Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study for the Second-Line Treatment of Hypertension in Patients With Autosomal Dominant Polycystic Kidney Disease; ACEI vs. CCB

NCT00890279 is registered in ClinicalTrials.gov with Ministry of Health, Labour and Welfare, Japan as lead sponsor.

NCT NCT00890279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00890279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study for the Second-Line Treatment of Hypertension in Patients With Autosomal Dominant Polycystic Kidney Disease; ACEI vs. CCB
Lead sponsor
Ministry of Health, Labour and Welfare, Japan
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2009
Completion date
November 30, 2012
Enrollment
160 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

kidney, polycystic, autosomal dominant